Michael Harrington

Track

Insider profile

Currently holds a position at Elanco Animal Health Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 35% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Elanco Animal Health Inc Sept. 1, 2018 -
Michael Harrington's trades of Elanco Animal Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
453.61
Quantity 32,880 -35.1%
Value US$4,548,282
US Inotiv Inc (NOTV)
Transaction date
Purchase
Price
118.43
Quantity 97,840 +35.0%
Value US$2,877,501
Transaction date
Purchase
Price
271.83
Quantity 86,060 -35.9%
Value US$1,841,000
Transaction date
Purchase
Price
16.29
Quantity 3,100 +4.2%
Value US$50,494
Transaction date
Purchase
Price
29.25
Quantity 2,500 +9.7%
Value US$73,122
Transaction date
Purchase
Price
23.84
Quantity 4,000 +31.3%
Value US$95,360
Transaction date
Planned sale
Price
116.72
Quantity 16,000 -12.7%
Value US$1,867,520
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-12
B Purchase
32,880 -35.1%
453.61
US$4,548,282 		32,880 -35.1% 453.61 US$4,548,282
2024-12-10 2024-12-06
US Inotiv Inc (NOTV)
B Purchase
97,840 +35.0%
118.43
US$2,877,501 		97,840 +35.0% 118.43 US$2,877,501
2024-08-26 2024-08-22
B Purchase
86,060 -35.9%
271.83
US$1,841,000 		86,060 -35.9% 271.83 US$1,841,000
2024-03-12 2024-03-08
B Purchase
3,100 +4.2%
16.29
US$50,494 		3,100 +4.2% 16.29 US$50,494
2021-12-02 2021-11-30
B Purchase
2,500 +9.7%
29.25
US$73,122 		2,500 +9.7% 29.25 US$73,122
2020-03-11 2020-03-09
B Purchase
4,000 +31.3%
23.84
US$95,360 		4,000 +31.3% 23.84 US$95,360
2019-06-04 2019-06-03
PlS Planned sale
16,000 -12.7%
116.72
US$1,867,520 		16,000 -12.7% 116.72 US$1,867,520